Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Oncotarget
|
January 10, 2018
Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing
Masaoki Ito, Yoshihiro Miyata, Shoko Hirano, et al.
Cell Communication and Signaling : CCS
|
May 11, 2025
Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12C
Masaoki Ito, Yoshihiro Miyata, Shoko Hirano, et al.
Cancer Research
|
April 17, 2023
FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung
Koichi Tomoshige, William D Stuart, Iris M Fink-Baldauf, et al.
Translational Lung Cancer Research
|
September 27, 2019
Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines
Jordi Codony-Servat, Santiago Viteri, Carles Codony-Servat, et al.
Clinical Lung Cancer
|
March 20, 2019
Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer
Jordi Codony-Servat, Carles Codony-Servat, Andrés Felipe Cardona, et al.
Biorxiv : the Preprint Server for Biology
|
July 1, 2024
Patho-transcriptomic analysis of invasive mucinous adenocarcinoma of the lung (IMA): comparison with lung adenocarcinoma with signet ring cell features (SRCC)
William D Stuart, Masaoki Ito, Iris-Fink Baldauf, et al.
Cells
|
September 13, 2025
Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon <i>EGFR</i> Mutations-An In Vitro Study
Hana Oiki, Kenichi Suda, Akira Hamada, et al.
Expert Review of Respiratory Medicine
|
August 15, 2019
Characterising acquired resistance to erlotinib in non-small cell lung cancer patients
Niki Karachaliou, Jordi Codony-Servat, Jillian Wilhelmina Paulina Bracht, et al.
Ebiomedicine
|
November 27, 2018
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)
Niki Karachaliou, Andres Felipe Cardona, Jillian Wilhelmina Paulina Bracht, et al.
Journal of Cancer Research and Clinical Oncology
|
April 2, 2021
Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung
Daisuke Ueda, Masaoki Ito, Yasuhiro Tsutani, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Oncotarget
|
January 10, 2018
Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing
Masaoki Ito, Yoshihiro Miyata, Shoko Hirano, et al.
Cell Communication and Signaling : CCS
|
May 11, 2025
Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12C
Masaoki Ito, Yoshihiro Miyata, Shoko Hirano, et al.
Cancer Research
|
April 17, 2023
FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung
Koichi Tomoshige, William D Stuart, Iris M Fink-Baldauf, et al.
Translational Lung Cancer Research
|
September 27, 2019
Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines
Jordi Codony-Servat, Santiago Viteri, Carles Codony-Servat, et al.
Clinical Lung Cancer
|
March 20, 2019
Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer
Jordi Codony-Servat, Carles Codony-Servat, Andrés Felipe Cardona, et al.
Biorxiv : the Preprint Server for Biology
|
July 1, 2024
Patho-transcriptomic analysis of invasive mucinous adenocarcinoma of the lung (IMA): comparison with lung adenocarcinoma with signet ring cell features (SRCC)
William D Stuart, Masaoki Ito, Iris-Fink Baldauf, et al.
Cells
|
September 13, 2025
Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon <i>EGFR</i> Mutations-An In Vitro Study
Hana Oiki, Kenichi Suda, Akira Hamada, et al.
Expert Review of Respiratory Medicine
|
August 15, 2019
Characterising acquired resistance to erlotinib in non-small cell lung cancer patients
Niki Karachaliou, Jordi Codony-Servat, Jillian Wilhelmina Paulina Bracht, et al.
Ebiomedicine
|
November 27, 2018
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)
Niki Karachaliou, Andres Felipe Cardona, Jillian Wilhelmina Paulina Bracht, et al.
Journal of Cancer Research and Clinical Oncology
|
April 2, 2021
Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung
Daisuke Ueda, Masaoki Ito, Yasuhiro Tsutani, et al.
Page
of 7